Works about FLUOROURACIL

Results: 4910

Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial.

Published in:

Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00344-3

By:

Lyhne, Johanne D.;
Hansen, Vibeke B.;
Vestergaard, Lone D.;
Hosbond, Susanne E.;
Busk, Martin;
Gnanaganesh, Mayooran;
Maae, Else;
Havelund, Birgitte M.;
Hansen, Torben F.;
Timm, Signe;
Jensen, Lars H.;
Lyhne, Mads D.

Publication type:

Article

The combined effects of 5-fluorouracil and Turkish propolis extract on EPGF and KRAS expressions and apoptotic cascade changing in rat colon cancer model.

Published in:

Veterinary Journal of Ankara University / Ankara Universitesi Veteriner Fakultesi Dergisi, 2025, v. 72, n. 2, p. 219, doi. 10.33988/auvfd.1513024

By:

KURTDEDE, Efe;
ALÇIĞIR, Mehmet Eray;
ŞAHİN, Yaşar

Publication type:

Article

SONOCRYSTALLIZATION OF A NOVEL SYNTHESIZED ANTICANCER DERIVATIVE OF 2-THIOURACIL-6-SULPHONAMIDE TO ENHANCE ITS WATER SOLUBILITY.

Published in:

Obstetrics & Gynaecology Forum, 2024, v. 34, n. 3, p. 1587

By:

Jawad, Mahmood J.;
Ahjel, Salam W.;
Abbas, Firas G.;
Awad, Samir M.;
El-Shehery, Mohamed F.;
Mahmoud, Mohamed;
Hafez, Mohamed M.

Publication type:

Article

Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors.

Published in:

Cancers, 2025, v. 17, n. 9, p. 1561, doi. 10.3390/cancers17091561

By:

Maratta, Maria Grazia;
Sparagna, Ileana;
Occhipinti, Denis;
Roca, Luigi;
Sgambato, Margherita;
Raia, Salvatore;
Bianchi, Antonio;
Chiloiro, Sabrina;
Rossi, Ernesto;
Rindi, Guido;
Tortora, Giampaolo;
Schinzari, Giovanni

Publication type:

Article

Isoguanosine-Induced ER Stress via AMPK Enhances Chemosensitivity in OSCC.

Published in:

Journal of Dental Research, 2025, v. 104, n. 6, p. 668, doi. 10.1177/00220345241303168

By:

Yao, J.;
Song, S.;
Liu, T.;
Wang, J.;
Li, C.;
Liu, J.;
Yuan, Y.;
Zhao, H.

Publication type:

Article

ارزیابی اثرات ضد سرطانى فن اتیل استر کافئیک اسید [CAPE] به همراه FU- از طریق بیان ژنهای دخیل در آپوپتوزیس بر رده سلولی سرطانی کولورکتال [۷۴۲-SW ].

Published in:

Journal of Mazandaran University of Medical Sciences (JMUMS), 2025, v. 35, n. 244, p. 65

By:

محمد شکرزاده;
رامین عطایی;
شقایق آقاجان شاک;
امیر حسین سلمان &#1605

Publication type:

Article

Rare occurrence of hand-foot syndrome due to paclitaxel: A rare case report.

Published in:: 2018
Publication type:: Case Study

5-Fluorouracil associated encephalopathy: Case report.

Published in:

2005

By:

Yadav, B.S.;
Sharma, S.C.

Publication type:

Report

CD81 Is Essential for the Re-entry of Hematopoietic Stem Cells to Quiescence following Stress-Induced Proliferation Via Deactivation of the Akt Pathway.

Published in:

PLoS Biology, 2011, v. 9, n. 9, p. 1, doi. 10.1371/journal.pbio.1001148

By:

Lin, Kuanyin K.;
Rossi, Lara;
Boles, Nathan C.;
Hall, Brian E.;
George, Thaddeus C.;
Goodell, Margaret A.

Publication type:

Article

Inclusion Complexes Between β‐cyclodextrin and the Anticancer Drug 5‐Fluorouracil for its Solubilization: a Molecular Dynamics Study at Different Stoichiometries.

Published in:

Macromolecular Symposia, 2022, v. 404, n. 1, p. 1, doi. 10.1002/masy.202100305

By:

Raffaini, Giuseppina;
Elli, Stefano;
Ganazzoli, Fabio;
Catauro, Michelina

Publication type:

Article

Effect of PEGylation on the Structure and Drug Loading Capacity of PAMAM-G4 Dendrimers: A Molecular Modeling Approach on the Complexation of 5-Fluorouracil with Native and PEGylated PAMAM-G4.

Published in:

Macromolecular Chemistry & Physics, 2015, v. 216, n. 16, p. 1689, doi. 10.1002/macp.201500179

By:

Barraza, Luis F.;
Jiménez, Verónica A.;
Alderete, Joel B.

Publication type:

Article

Metal-Organic-Framework-Coated Optical Fibers as Light-Triggered Drug Delivery Vehicles.

Published in:

Advanced Functional Materials, 2016, v. 26, n. 19, p. 3244, doi. 10.1002/adfm.201505260

By:

Nazari, Marziyeh;
Rubio‐Martinez, Marta;
Tobias, Gerard;
Barrio, Jorge Pérez;
Babarao, Ravichandar;
Nazari, Fatemeh;
Konstas, Kristina;
Muir, Benjamin W.;
Collins, Stephen F.;
Hill, Anita J.;
Duke, Mikel C.;
Hill, Matthew R.

Publication type:

Article

Synthesis and characterization of a novel chitosan based E. coli cytosine deaminase nanocomposite for potential application in prodrug enzyme therapy.

Published in:

Biotechnology Letters, 2011, v. 33, n. 1, p. 153, doi. 10.1007/s10529-010-0416-4

By:

Yata, Vinod;
Ghosh, Siddhartha

Publication type:

Article

Michael Addition of Pyrimidine with Disaccharide Acrylates Catalyzed in Organic Medium with Lipase M from Mucor javanicus.

Published in:

Biotechnology Letters, 2006, v. 28, n. 18, p. 1503, doi. 10.1007/s10529-006-9116-5

By:

Dai, Hong-Xia;
Yao, Shi-Ping;
Wang, Jian

Publication type:

Article

Proteome analysis of 5-fluorouracil-resistance-associated protein in human gastric cancer cells.

Published in:

Biotechnology Letters, 2002, v. 24, n. 14, p. 1141, doi. 10.1023/A:1016122716886

By:

Park, Saeyoung;
Lee, Mina;
Kim, Hae-Yeong;
Jeoung, Doo-Il

Publication type:

Article

Immunotherapy response evaluation with F-FDG-PET in patients with advanced stage renal cell carcinoma.

Published in:

World Journal of Urology, 2013, v. 31, n. 4, p. 841, doi. 10.1007/s00345-011-0723-y

By:

Gilles, Rozemarie;
Geus-Oei, Lioe-Fee;
Mulders, Peter;
Oyen, Wim

Publication type:

Article

Strategies to Improve the Anticancer Action of 5-Fluorouracil By Using Magnetically Targeted Drug Delivery Systems.

Published in:

Materials Research Innovations, 2023, v. 27, n. 4, p. 253, doi. 10.1080/14328917.2022.2130399

By:

Choubey, Jyoti;
Bajpai, A. K

Publication type:

Article

Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy.

Published in:

2001

By:

Fujikawa, Akira;
Tsuchiya, Kazuhiro;
Katase, Shichiro;
Kurosaki, Yoshihisa;
Hachiya, Junichi;
Fujikawa, A;
Tsuchiya, K;
Katase, S;
Kurosaki, Y;
Hachiya, J

Publication type:

journal article

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 773, doi. 10.1007/s00280-011-1753-2

By:

Petrini, Iacopo;
Lencioni, Monica;
Ricasoli, Miriam;
Iannopollo, Mauro;
Orlandini, Cinzia;
Oliveri, Filippo;
Bartolozzi, Carlo;
Ricci, Sergio

Publication type:

Article

A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 743, doi. 10.1007/s00280-011-1762-1

By:

Fakih, M.;
Groman, A.;
McMahon, J.;
Wilding, G.;
Muindi, J.

Publication type:

Article

Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 301, doi. 10.1007/s00280-011-1700-2

By:

Afzal, Shoaib;
Jensen, Søren;
Sørensen, Jens;
Henriksen, Trine;
Weimann, Allan;
Poulsen, Henrik

Publication type:

Article

5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 57, doi. 10.1007/s00280-011-1669-x

By:

Jensen, Søren;
Sørensen, Jens

Publication type:

Article

Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1449, doi. 10.1007/s00280-011-1641-9

By:

Xavier, Cristina;
Lima, Cristovao;
Rohde, Mikkel;
Pereira-Wilson, Cristina

Publication type:

Article

Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1611, doi. 10.1007/s00280-011-1661-5

By:

Staveren, Maurice;
Theeuwes-Oonk, Barbara;
Guchelaar, Henk;
Kuilenburg, André;
Maring, Jan

Publication type:

Article

First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1173, doi. 10.1007/s00280-011-1602-3

By:

Pelzer, Uwe;
Arnold, Dirk;
Reitzig, Peter;
Herrenberger, Julia;
Korsten, Friedrich;
Kindler, Manfred;
Stieler, Jens;
Dörken, Bernd;
Riess, Hanno;
Oettle, Helmut

Publication type:

Article

Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1207, doi. 10.1007/s00280-011-1604-1

By:

De Stefano, Alfonso;
Carlomagno, Chiara;
Pepe, Stefano;
Bianco, Roberto;
De Placido, Sabino

Publication type:

Article

A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 905, doi. 10.1007/s00280-011-1562-7

By:

Choi, Yoon;
Kim, Tae;
Lee, Sung;
Hong, Yong;
Ryu, Min-Hee;
Lee, Jae-Lyun;
Chang, Heung;
Kang, Yoon-Koo

Publication type:

Article

Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 1017, doi. 10.1007/s00280-011-1584-1

By:

Lim, Kyu-Hyoung;
Kim, Tae-Yong;
Lee, Kyung-Hun;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue

Publication type:

Article

Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 1067, doi. 10.1007/s00280-011-1588-x

By:

Lima Lopes, Gilberto;
Dicksey, Jennifer;
Peters, William;
Palalay, Melvin;
Chang, Alex

Publication type:

Article

5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 823, doi. 10.1007/s00280-011-1666-0

By:

Cordier, Pierre-Yves;
Nau, André;
Ciccolini, Joseph;
Oliver, Manuela;
Mercier, Cédric;
Lacarelle, Bruno;
Peytel, Eric

Publication type:

Article

Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 603, doi. 10.1007/s00280-010-1515-6

By:

Li, Yan;
Revalde, Jezrael;
Reid, Glen;
Paxton, James

Publication type:

Article

Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 713, doi. 10.1007/s00280-010-1540-5

By:

Soares, Pedro;
Lima-Junior, Roberto;
Mota, José;
Justino, Priscilla;
Brito, Gerly;
Ribeiro, Ronaldo;
Cunha, Fernando;
Souza, Marcellus

Publication type:

Article

UGT1A11/28 and 1/ 6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 279, doi. 10.1007/s00280-010-1485-8

By:

Sunakawa, Yu;
Ichikawa, Wataru;
Fujita, Ken-ichi;
Nagashima, Fumio;
Ishida, Hiroo;
Yamashita, Keishi;
Mizuno, Keiko;
Miwa, Keisuke;
Kawara, Kaori;
Akiyama, Yuko;
Araki, Kazuhiro;
Yamamoto, Wataru;
Miya, Toshimichi;
Narabayashi, Masaru;
Ando, Yuichi;
Hirose, Takashi;
Saji, Shigehira;
Sasaki, Yasutsuna

Publication type:

Article

Clinical impact of K- ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 317, doi. 10.1007/s00280-010-1496-5

By:

Chang, Myung;
Lee, In;
Si, Yoon;
Lee, Kyu;
Woo, In-Sook;
Byun, Jae

Publication type:

Article

The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 497, doi. 10.1007/s00280-010-1503-x

By:

Van, Trung;
Hanibuchi, Masaki;
Kakiuchi, Soji;
Sato, Seidai;
Kuramoto, Takuya;
Goto, Hisatsugu;
Mitsuhashi, Atsushi;
Nishioka, Yasuhiko;
Akiyama, Shin-ichi;
Sone, Saburo

Publication type:

Article

Determination of 5-fluorouracil and dihydrofluorouracil levels by using a liquid chromatography-tandem mass spectrometry method for evaluation of dihydropyrimidine dehydrogenase enzyme activity.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 525, doi. 10.1007/s00280-010-1528-1

By:

Serdar, Muhittin;
Sertoğlu, Erdim;
Uyanık, Metin;
Tapan, Serkan;
Akın, Okhan;
Cihan, Murat

Publication type:

Article

Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 37, doi. 10.1007/s00280-010-1424-8

By:

Cascinu, Stefano;
Galizia, Eva;
Labianca, Roberto;
Ferraù, Francesco;
Pucci, Francesca;
Silva, Rosa;
Luppi, Gabriele;
Beretta, Giordano;
Berardi, Rossana;
Scartozzi, Mario

Publication type:

Article

Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 87, doi. 10.1007/s00280-010-1451-5

By:

Wu, Zhen-Qian;
Han, Xiao-Dong;
Wang, Yu;
Yuan, Ke-Li;
Jin, Zhi-Ming;
Di, Jian-Zhong;
Yan, Jun;
Pan, Ye;
Zhang, Pin;
Huang, Xin-Yu;
Wang, Zhi-Gang;
Zheng, Qi

Publication type:

Article

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1055, doi. 10.1007/s00280-010-1400-3

By:

Konings, Inge;
Sleijfer, Stefan;
Mathijssen, Ron;
Bruijn, Peter;
Ghobadi Moghaddam-Helmantel, Inge;
Dam, Linda;
Wiemer, Erik;
Verweij, Jaap;
Loos, Walter

Publication type:

Article

Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1085, doi. 10.1007/s00280-010-1409-7

By:

Medeiros, C.;
Leitão, R.;
Macedo, R.;
Barboza, D.;
Gomes, A.;
Nogueira, N.;
Alencar, N.;
Ribeiro, R.;
Brito, G.

Publication type:

Article

Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 963, doi. 10.1007/s00280-010-1476-9

By:

Garg, Madhu;
Ackland, Stephen

Publication type:

Article

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 1, p. 41, doi. 10.1007/s00280-010-1281-5

By:

Dalla Chiesa, Matteo;
Tomasello, Gianluca;
Buti, Sebastiano;
Rovere, Rodrigo;
Brighenti, Matteo;
Lazzarelli, Silvia;
Donati, Gianvito;
Passalacqua, Rodolfo

Publication type:

Article

Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study.

Published in:

2010

By:

Tanaka, Yoshihiro;
Yoshida, Kazuhiro;
Sanada, Yuichi;
Osada, Shinji;
Yamaguchi, Kazuya;
Takahashi, Takao

Publication type:

Report

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1113, doi. 10.1007/s00280-010-1269-1

By:

Dickson, Mark A.;
Shah, Manish A.;
Rathkopf, Dana;
Tse, Archie;
Carvajal, Richard D.;
Nian Wu;
Lefkowitz, Robert A.;
Gonen, Mithat;
Cane, Lauren M.;
Dials, Heather J.;
Schwartz, Gary K.

Publication type:

Article

Phase II study of pemetrexed in patients with advanced neuroendocrine tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 961, doi. 10.1007/s00280-010-1248-6

By:

Chan, Jennifer A.;
Zhu, Andrew X.;
Stuart, Keith;
Bhargava, Pankaj;
Earle, Craig C.;
Clark, Jeffrey W.;
Casey, Carolyn;
Regan, Eileen;
Kulke, Matthew H.

Publication type:

Article

A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer.

Published in:

2010

By:

Shiozawa, Manabu;
Akaike, Makoto;
Sugano, Nobuhiro;
Tsuchida, Kazuhito;
Yamamoto, Naoto;
Morinaga, Soichiro

Publication type:

Report

Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 819, doi. 10.1007/s00280-009-1224-1

By:

Letari, Ornella;
Booth, Catherine;
Bonazzi, Albino;
Garofalo, Paolo;
Makovec, Francesco;
Rovati, Lucio C.;
Caselli, Gianfranco

Publication type:

Article

Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 4, p. 643, doi. 10.1007/s00280-009-1203-6

By:

Kyong Hwa Park;
Jeong Sun Kim;
Yong Park;
Hee Yeon Seo;
Young Je Park;
In Keun Choi;
Sang Chul Oh;
Jae Hong Seo;
Chul Yong Kim;
Kwang Yoon Jung;
Sang Won Shin;
Yeul Hong Kim;
Jun Suk Kim;
Nam Joon Lee

Publication type:

Article

Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 517, doi. 10.1007/s00280-009-1192-5

By:

Matsunaga, Toshiyuki;
Tsuji, Yoshitaka;
Kaai, Kairyu;
Kohno, Saki;
Hirayama, Renzo;
Alpers, David H.;
Komoda, Tsugikazu;
Hara, Akira

Publication type:

Article

Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 559, doi. 10.1007/s00280-009-1196-1

By:

Loupakis, Fotios;
Masi, Gianluca;
Fornaro, Lorenzo;
Vasile, Enrico;
Allegrini, Giacomo;
Fontana, Eloise;
Granetto, Cristina;
Salvatore, Lisa;
Mentuccia, Lucia;
Andreuccetti, Michele;
Cortesi, Enrico;
Merlano, Marco;
Cascinu, Stefano;
Falcone, Alfredo

Publication type:

Article